NASDAQ
Pasithea Therapeutics Corp. (KTTA) has a current ratio of 11.35x as of Monday, May 25, 2026. This represents a 69.78% decrease compared to its 12-month average of 37.56x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.